The role of initial clinical presentation, comorbidity and treatment in multiple myeloma patients on survival: a detailed population-based cohort study (Q40309114)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 March 2017

Language	Label	Description	Also known as
English	The role of initial clinical presentation, comorbidity and treatment in multiple myeloma patients on survival: a detailed population-based cohort study	scientific article published on 3 March 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

The role of initial clinical presentation, comorbidity and treatment in multiple myeloma patients on survival: a detailed population-based cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

B E Oortgiesen

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

E N van Roon

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

P Joosten

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

R E Kibbelaar

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

H Storm

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

S Hovenga

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

B van Rees

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

G Woolthuis

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

N Veeger

9

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

E G de Waal

10

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

M Hoogendoorn

11

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

3 March 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

73

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

771-778

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Age and aging in blood disorders: multiple myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Restoration of renal function in patients with newly diagnosed multiple myeloma is not associated with improved survival: a population-based study

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Recent major improvement in long-term survival of younger patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00228-017-2227-1

21 January 2018

Improved long-term survival in multiple myeloma up to the age of 80 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/28258356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NCI SEER public-use data: applications and limitations in oncology research.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28258356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index

1 reference

https://pubmed.ncbi.nlm.nih.gov/28258356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00228-017-2227-1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40309114&oldid=2203590599"